TurboVets is fully live. For support, please submit tickets in app.
Sign In to TurboVets
Your Data is Protected. Never Sold. Never Used for Profit.
Read our FAQ
6000
§ 4.79 Schedule of ratings—eye.

Eye inflammation (uveitis, iritis, or choroiditis)

Inflammation of the middle or inner layers of the eye, including the iris or choroid.

What the rating means

VA rates choroidopathy — which covers uveitis, iritis, cyclitis, and choroiditis — under the General Rating Formula for Diseases of the Eye. This formula gives you two ways to reach a rating: through the visual impairment your condition causes, or through incapacitating episodes over the past 12 months. VA uses whichever approach produces the higher rating.

When rating by incapacitating episodes, the number of documented treatment visits in the past 12 months determines the percentage. Seven or more visits results in a 60% rating. At least 5 but fewer than 7 visits results in 40%. At least 3 but fewer than 5 visits results in 20%. At least 1 but fewer than 3 visits results in 10%. A visit counts only if you went to a provider specifically for treatment of the eye condition — not for a routine check or unrelated care. Examples of qualifying treatment include systemic immunosuppressants or biologic agents, intravitreal or periocular injections, laser treatments, and other surgical interventions.

For the visual impairment path, VA applies separate formulas covering visual acuity, visual field loss, and other eye-specific criteria found in 38 CFR 4.75–4.78 and diagnostic codes 6061–6091.

Evidence that helps

To support a rating based on incapacitating episodes, the most important evidence is a clear record of each clinic visit made specifically to treat your eye condition within the past 12 months. Medical records that show the date of each visit, the provider seen, and the treatment given — such as an injection, a laser procedure, a prescription for immunosuppressants or biologic agents, or another surgical intervention — directly address the visit-count criteria at each rating level.

Records showing fewer than three treatment visits support the 10% criteria. Records confirming at least three visits build toward 20%, at least five toward 40%, and seven or more toward 60%. Pharmacy records, surgical reports, infusion logs, and ophthalmology or rheumatology notes can all help document that a visit was for treatment rather than routine monitoring.

If your condition has also reduced your vision, records of visual acuity testing, visual field testing, or other eye examination findings are relevant to the visual impairment rating path. Statements from you or people who know you describing how flare-ups affect your ability to work or carry out daily activities can help show the severity and frequency of episodes.

Secondary conditions

Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.